Clinical evaluation of a highly multiplexed CRISPR-based diagnostic assay for diagnosing lower respiratory tract infection: a prospective cohort study-Reference-Cited by-同舟云学术

Clinical evaluation of a highly multiplexed CRISPR-based diagnostic assay for diagnosing lower respiratory tract infection: a prospective cohort study

Published:2024-09-12 Issue: Volume: Page:1-11
ISSN:2374-4235
Container-title:Infectious Diseases
language:en
Short-container-title:Infectious Diseases

Author:

Lou Hui¹,Wang Xiaojia²,Jiang Qiuting¹,Li Xi³,Yao Yake¹,Chen Qi¹,Chen Linxing¹,Zhang Shanshan¹,Yu Yunsong⁴,Liu Chao²,Zhou Hua¹^ORCID

Affiliation:

1. Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

2. Medical Department, Hangzhou Matridx Biotechnology Co., Ltd, Hangzhou, Zhejiang, China

3. Department of Clinical Laboratory, Laboratory Medicine Center, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China

4. Department of Infectious Disease, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China

Funder

the Key R&D Plan of the Ministry of Science and Technology of China

the Research and Development Program of Zhejiang Province

National Natural Science Foundation of China

Medical and Health Technology Project of Zhejiang Province

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/23744235.2024.2402921

Reference27 articles.

1. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021

2. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

3. Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019

4. Infection and co-infection patterns of community-acquired pneumonia in patients of different ages in China from 2009 to 2020: a national surveillance study

5. Timing of antibiotic therapy in the ICU